GlassScriptPhysician profile
Angie R Pei
NPI 1548485535
$3,503.49
in general payments reported to CMS, 2019-2025
17 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $156 · 2021: $164 · 2022: $256 · 2023: $825 · 2024: $771 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,652.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $718.95 | 2022-2025 | Xiidra, Miebo, Infuse |
| Alcon Vision LLC | $586.72 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Coopervision INC. | $307.57 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $306.84 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $286.76 | 2022-2025 | Acuvue |
| Genentech USA, INC. | $217.80 | 2023 | |
| Amgen INC. | $146.55 | 2024 | Tepezza |
| Dompe US, INC. | $142.85 | 2025 | Oxervate |
| Horizon Therapeutics Plc | $139.56 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $121.83 | 2025 | Xdemvy |
| Allergan, INC. | $121.09 | 2022 | |
| Abb Con-Cise Optical Group LLC | $119.50 | 2019-2022 | |
| Sight Sciences, INC. | $112.24 | 2023 | Omni Surgical System |
| Abbvie INC. | $97.01 | 2023 | |
| Genzyme Corporation | $50.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $14.55 | 2022 | |
| Visioneering Technologies, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Pei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.